SPECCHIA, GIORGINA
 Distribuzione geografica
Continente #
EU - Europa 5.637
NA - Nord America 288
AS - Asia 102
SA - Sud America 16
AF - Africa 4
Totale 6.047
Nazione #
IT - Italia 5.565
US - Stati Uniti d'America 285
SG - Singapore 42
CN - Cina 40
SE - Svezia 28
BR - Brasile 13
GB - Regno Unito 12
KR - Corea 8
DE - Germania 6
FI - Finlandia 5
PL - Polonia 4
FR - Francia 3
AE - Emirati Arabi Uniti 2
AT - Austria 2
BE - Belgio 2
CA - Canada 2
ES - Italia 2
IE - Irlanda 2
IN - India 2
JO - Giordania 2
JP - Giappone 2
MA - Marocco 2
NL - Olanda 2
TR - Turchia 2
AR - Argentina 1
BY - Bielorussia 1
DZ - Algeria 1
HR - Croazia 1
IL - Israele 1
MX - Messico 1
PT - Portogallo 1
RU - Federazione Russa 1
UY - Uruguay 1
VE - Venezuela 1
VN - Vietnam 1
ZA - Sudafrica 1
Totale 6.047
Città #
Cagliari 5.430
Uta 122
Ashburn 44
Dallas 32
Fairfield 25
Houston 19
Singapore 18
Ann Arbor 17
Woodbridge 16
Cambridge 15
Boardman 14
Seattle 13
Wilmington 11
Los Angeles 9
Beijing 8
Seoul 8
Shanghai 8
New York 7
Nyköping 7
Hefei 6
Chandler 5
Santa Clara 5
Buffalo 4
Helsinki 4
Bexley 3
London 3
Warsaw 3
Amman 2
Atlanta 2
Brussels 2
Chicago 2
Dearborn 2
Orem 2
Porto Alegre 2
Redondo Beach 2
San Diego 2
Tokyo 2
Venice 2
Abu Dhabi 1
Amsterdam 1
Biên Hòa 1
Brandenburg 1
Buenos Aires 1
Campinas 1
Casablanca 1
Chaowai 1
Charleston 1
Cidade Dutra 1
Coquitlam 1
Coro 1
Dubai 1
Dublin 1
Dungannon 1
Franca 1
Frankfurt am Main 1
Goiânia 1
Guangzhou 1
Helena 1
Irecê 1
Islington 1
Istanbul 1
Jacksonville 1
Jesúpolis 1
Johannesburg 1
Lappeenranta 1
Letterkenny 1
Lisbon 1
Milan 1
Minsk 1
Montevideo 1
New Delhi 1
North Bergen 1
Paris 1
Pinheiro 1
Portsmouth 1
Pune 1
Querétaro 1
Rabat 1
Redmond 1
Redwood City 1
San Mateo 1
Santo André 1
Santos 1
Stockholm 1
São Paulo 1
Sétif 1
Tacaimbó 1
Tel Aviv 1
Tianjin 1
Toronto 1
Umeå 1
Vienna 1
Weitang 1
Wroclaw 1
Totale 5.934
Nome #
Permanent Discontinuation of Tyrosine Kinase Inhibitor Frontline Therapy in Patients with Chronic Phase Chronic Myeloid Leukemia Patients during the First 36 Months of Treatment: A "Campus CML" Study 2.884
Cardiovascular toxicity in patients with chronic myeloid leukemia treated with second-generation tyrosine kinase inhibitors in the real-life practice: Identification of risk factors and the role of prophylaxis 2.086
Analysis of Early Events during the First Year of Tyrosine Kinase Inhibitor Therapy in Patients with Chronic Phase - Chronic Myeloid Leukemia: A "Campus CML" Study 646
Determinants of frontline tyrosine kinase inhibitor choice for patients with chronic-phase chronic myeloid leukemia: A study from the Registro Italiano LMC and Campus CML 446
Totale 6.062
Categoria #
all - tutte 7.393
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.393


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021236 0 0 0 0 0 72 41 32 9 39 29 14
2021/2022465 17 17 14 21 23 10 17 36 65 80 100 65
2022/2023656 86 96 162 42 23 90 10 71 15 13 29 19
2023/2024418 25 11 19 20 31 100 49 38 17 24 40 44
2024/20253.568 1.363 290 1.468 132 69 82 95 11 19 10 9 20
2025/2026165 39 11 47 33 32 3 0 0 0 0 0 0
Totale 6.062